L. Rufián

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

S. Mercadal, E. Barragán, L. Villalón, 2022, Scientific Reports.

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma

N. Bolli, M. Samur, Y. Tai, 2021, Cancers.

Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT

T. Baumann, I. Rapado, M. Mollejo, 2023, Leukemia.

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

A. Mead, M. Rozman, N. Cross, 2022, Blood advances.

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

T. Baumann, I. Rapado, M. Cedena, 2023, Frontiers in Immunology.

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease

P. Algara, M. Mollejo, J. Martínez-López, 2023, Cancers.

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges

I. Rapado, S. Barrio, R. Colmenares, 2024, Frontiers in immunology.